Title Multiple sclerosis therapeutics / editors, Jeffrey A. Cohen, Richard A. Rudick

Edition 3rd ed Published Abingdon : Informa Healthcare ; Boca Raton, FL : Distributed in North and South America by Taylor & Francis, 2007

Click on the following:
ProQuest Ebook Central

Copies

Description 1 online resource (xxxi, 896 pages) : illustrations Contents Introduction. Aspects of multiple sclerosis that relate to trial design and clinical management. Biological concepts of multiple sclerosis pathogenesis and relationship to treatment. The multiple sclerosis disease process as characterized by magnetic resonance imaging -- Clinical trial methodology. Measures of neurological impairment and disability in multiple sclerosis. Health-related quality of life assessment in multiple sclerosis. Measures of gadolinium enhancement, T1 black holes and T2-hyperintense lesions on magnetic resonance imaging in multiple sclerosis. Measures of magnetization transfer in multiple sclerosis. Measurement of central nervous system atrophy in multiple sclerosis. Axonal pathology in patients with multiple sclerosis. Functional imaging in multiple sclerosis. Magnetic resonance imaging of pathway-specific structure and function in multiple sclerosis. Optical coherence tomography to monitor neuronal integrity in multiple sclerosis. Biomarkers in multiple sclerosis. The process of drug development and approval in the United States, the European Union, and Canada. Selection and interpretation of end-points in multiple sclerosis clinical trials. Clinical trial logistics. The challenge of long-term studies in multiple sclerosis: use of pooled data, historical controls, and observational studies to determine efficacy. Alternative designs for multiple sclerosis clinical trials. Ethical considerations in multiple sclerosis clinical trials. Pharmacogenetics and phamacogenomics in multiple sclerosis -- Clinical trials of multiple sclerosis therapies. Interferons in relapsing-remitting multiple sclerosis. Interferons in secondary progressive multiple sclerosis. Neutralizing antibodies directed against interferon [beta]. Glatiramer acetate as therapy for multiple sclerosis. Use of mitoxantrone to treat multiple sclerosis. Use of cyclophosphamide and other immunosuppressants to treat multiple sclerosis. Natalizumab in multiple sclerosis. High-dose methylpredisolone in the treatment of multiple sclerosis. Intravenous immunoglobulin in multiple sclerosis. Therapeutic plasma exchange for multiple sclerosis. Statins in multiple sclerosis. Stem cell transplantatation for multiple sclerosis. T cell-based therapies for multiple sclerosis and related diseases. Chemokines and central nervous system inflammation: relevance to multiple sclerosis. Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis. Neuroprotection in multiple sclerosis. Combination therapy in multiple sclerosis. Fampridine in multiple sclerosis. Complementary and alternative treatments in multiple sclerosis -- Therapy in clinical practice. Disease-modifying therapy for multiple sclerosis in clinical practice. Treatment for patients with primary progressive multiple sclerosis. Use of magnetic resonance imaging in clinical management of multiple sclerosis. Fatigue in multiple sclerosis. Management of spasticity in multiple sclerosis. Management of bladder and sexual dysfunction in multiple sclerosis. Depression in multiple sclerosis. Treatment of pain, paresthesias, and paroxysmal disorders in multiple sclerosis. Rehabilitation in multiple sclerosis patients Summary Provides comprehensive information on clinical trial methodology and therapeutic modalities in multiple sclerosis. This edition reflects the advances in understanding of the pathophysiology of the disease. It also includes chapters on biomarkers in MS, pharmacogenomics, emerging therapeutic modalities, neuroprotection, and the use of OCT and MRI Notes Previous edition: London : Martin Dunitz, 2002 Bibliography Includes bibliographical references and index Notes Print version record Subject Multiple sclerosis. Multiple sclerosis -- Treatment Magnetic resonance imaging. Outcome assessment (Medical care) Multiple Sclerosis -- therapy Multiple Sclerosis Clinical Trials as Topic -- methods Magnetic Resonance Imaging Multiple Sclerosis -- pathology Outcome Assessment, Health Care Treatment Outcome Outcome and Process Assessment, Health Care HEALTH & FITNESS -- Diseases -- Alzheimer's & Dementia. MEDICAL -- Neurology. Outcome assessment (Medical care) Magnetic resonance imaging Multiple sclerosis Multiple sclerosis -- Treatment Form Electronic book Author Cohen, Jeffrey A. (Jeffrey Alan), 1954- Rudick, Richard A. ISBN 9780203012055 0203012054

  Permalink